Trials / Completed
CompletedNCT03387956
Intrathecal Atropine to Prevent Postoperative Nausea and Vomiting
Intravenous Dexamethasone Combined With Intrathecal Atropine to Prevent Morphine-related Nausea and Vomiting After Cesarean Delivery: A Randomized Double-blinded Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
optimal postoperative pain control with intrathecal morphine, with proper prevention of postoperative nausea and vomiting. Dexamethasone, and or atropine could offer some protection against nausea and vomiting.
Detailed description
One of the gold standards for analgesia following cesarean delivery is intrathecal morphine, which is not devoid of complications namely postoperative nausea and vomiting. We evaluated the antiemetic effect of intravenous dexamethasone combined with intrathecal atropine after cesarean delivery under spinal bupivacaine plus morphine anesthesia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intrathecal atropine | 100ug intrathecal atropine will be injected with spinal anesthesia |
| DRUG | dexamethasone | intravenous 8 mg dexamethasone (2ml). |
Timeline
- Start date
- 2017-03-20
- Primary completion
- 2017-07-28
- Completion
- 2017-08-10
- First posted
- 2018-01-02
- Last updated
- 2018-06-06
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03387956. Inclusion in this directory is not an endorsement.